THE #1 AV NEWS PUBLICATION. PERIOD.

Barco Demetra and Gnosco Dermicus Merge Into New Digital Health Skin Solutions Company

Barco’s Demetra business, a next-generation skin imaging solution, and Gnosco’s Dermicus business, a leading European teledermatology platform, have joined forces to help clinicians transform the diagnostic and treatment processes of skin conditions, when and where the patient needs it. The company, named Dermicus, will deliver teledermatology, telewoundcare and digital dermoscopy solutions.

Dermicus company logo

A seamless, unique fit

Together, the Dermicus platform and the Demetra skin imaging solution will provide a unique end-to-end offering for both specialist clinicians and collaborative networks of primary care professionals, dermatologists and wound care specialists. The Gnosco and Demetra teams will combine into a single entity, majority-owned by Barco.

“The synergy between our cultures, mission, and solutions will bring tremendous value to our clients. Gnosco has the experience of leading teledermatology implementations at scale in Sweden and the UK, while Demetra has built a strong client base in dermatology. Together we can accelerate our vision of helping our clients transform the way they diagnose and manage skin conditions,” says Dermicus CEO Peter Kinhan.

A dermatologist using the Demetra Scope to view a lesion on a patient's cheek

Leveraging entrepreneurship and expertise

Both Gnosco and Barco’s Healthcare division were built in close collaboration with leading healthcare providers. This will continue in the future. The focus on entrepreneurship will be maintained by setting Dermicus up as a separate entity, which is majority-owned by Barco, to ensure the global resources and expertise of Barco can continue to be leveraged. Gnosco’s co-founders, Daniel Eliasson and Dr Johan Heilborn, will take on leadership roles as COO and CMO respectively.

“This represents an important next step for Dermicus after years of investment and learning from leading some of Europe’s larger teledermatology implementations. As a combined team we can now expand to new regions and deepen our capabilities in telewoundcare and artificial intelligence, and continue to build on our new vision for digital dermoscopy,” says Daniel Eliasson, Dermicus COO.

Top